These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 756691)

  • 1. [Evaluation of biological activity of organic substances by measuring the physico-chemical parameters (author's transl)].
    Avico U; Cingolani E; Ciranni Signoretti E; Zuccaro P
    Ann Ist Super Sanita; 1978; 14(4):769-80. PubMed ID: 756691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relations between physical parameters and biological activity of organic substances. I. Solubility in water of the amorphous phase of some sulfonamides].
    Avico U; Cavazzutti G; Di Francesco R; Signoretti Ciranni E; Zuccaro P
    Farmaco Prat; 1975 Jan; 30(1):40-6. PubMed ID: 1183572
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of drug substances by modern liquid chromatography on silver impregnated silica gels.
    Aigner R; Spitzy H; Frei RW
    J Chromatogr Sci; 1976 Aug; 14(8):381-5. PubMed ID: 182708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical properties of drugs that control absorption rate after subcutaneous implantation.
    BALLARD BE; NELSON E
    J Pharmacol Exp Ther; 1962 Jan; 135():120-7. PubMed ID: 13864430
    [No Abstract]   [Full Text] [Related]  

  • 5. Gas chromatography of barbiturates, phenolic alkaloids, and xanthine bases: flash-heater methylation by means of trimethylanilinium hydroxide.
    Brochmann-Hanssen E; Oke TO
    J Pharm Sci; 1969 Mar; 58(3):370-1. PubMed ID: 5782038
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)].
    Hollenbach K; Mezösi J; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical parameters and biological activity of sulfonamides.
    Avico U; Zuccaro P; Cingolani E; Ciranni Signoretti E
    Farmaco Sci; 1985 Dec; 40(12):970-8. PubMed ID: 4092768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Solubility of drugs as criterion for drug liberation from fat-like, galenic bases (Cetylium phthalicum, lasupol G) with reference to viscosity increasing adjuvant substances].
    Voigt R; Falk G
    Pharmazie; 1968 Dec; 23(12):709-14. PubMed ID: 4304717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis and physico-chemical parameters of clanobutin (author's transl)].
    Klemm K; Krastinat W; Krüger U
    Arzneimittelforschung; 1979; 29(1):1-2. PubMed ID: 582102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complexometric determination of organic pharmaceutical preparations].
    Iavorskiĭ NP
    Farm Zh; 1968; 23(4):15-21. PubMed ID: 4387509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on drug nonequivalence. VIII. Solubilities of polymorphs and hydrate of mercaptopurine (author's transl)].
    Kuroda K; Yokoyama T; Umeda T; Kita Y; Konishi A; Kuroda T
    Yakugaku Zasshi; 1979 Jul; 99(7):745-51. PubMed ID: 575659
    [No Abstract]   [Full Text] [Related]  

  • 14. [Infrared spectroscopy of drugs. II. Basic principles, methods and application].
    Moll F
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1971 Jun; 41(6):145-61. PubMed ID: 4932767
    [No Abstract]   [Full Text] [Related]  

  • 15. [The determination of heat of complex formation by calorimetry (author's transl)].
    Samejima M; Yoshida M; Hirakawa Y
    Yakugaku Zasshi; 1975 Jun; 95(6):728-31. PubMed ID: 127035
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on Xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide). Part 1: Physico-chemical and chemical properties (author's transl)].
    Hempelmann FW
    Arzneimittelforschung; 1977; 27(11):2140-3. PubMed ID: 23792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MASCA-model of the biochemical-pharmacological drug research/part 1: Principle of the univariate structure-activity relationship and definitions of physico-chemical parameters (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Jul; 25(7):1006-8. PubMed ID: 1174406
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of a slightly soluble form of calcium alpha-glucoheptonate (author's transl)].
    Muller R; Bardon J; Arnaud Y; Champy J; Roland P
    Ann Pharm Fr; 1979; 37(7-8):301-8. PubMed ID: 539738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of 5-(4-oxo-delta3-cyclohexenyl)-5-allylbarbituric acid in rabbits (author's transl)].
    Nakashima K
    Yakugaku Zasshi; 1978 Jan; 98(1):133-6. PubMed ID: 641696
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro study of "availability of drugs. I. Resorption from the gastrointestinal tract].
    Stricker H
    Arzneimittelforschung; 1970 Mar; 20(3):391-6. PubMed ID: 5467513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.